AI for faster, safer, and more effective trials

The first and best speciality oncology focussed AI biomarker company; working with the leading biotech and pharma groups

What we do

Biologically meaningful grouping; beyond molecular subtyping

Illustration of cohort indexing: showing a few patient samples in the context of disease space.

We identify known and novel biologically-relevant subtypes and categorise trial participants into the appropriate groups with a consistency and precision that current pathology workflows cannot match.

Unique, expert-curated reference cohorts enable us to generate reliable patient stratification even from small trial populations.

Insights to power your trial recruitment, protocol design and in-trial management.

Immediate treatment response and disease progression insights

Illustration of cohort indexing: showing a few patient samples in the context of disease space.

Systematic, quantitative analysis of samples that accounts for molecular, demographic, and contextual data.

Enable analysis of the entire sample via our heat-mapping of the whole slide to identify areas of interest.

Interpretable and reproducible insights you can trust.

Consistent analysis; super-powering your pathology capabilities

Systematic, quantitative analysis of samples that accounts for molecular, demographic, and contextual data.

Enable analysis of the entire sample via our heat-mapping of the whole slide to identify areas of interest.

Interpretable and reproducible insights you can trust.

Case studies

We have delivered trial-defining insights to world-class biopharma companies

1

Stratify patients at screening

Our platform's blind analysis for a top 5-biopharma identified patients in their trial cohort that had been incorrectly recruited to trial through manual pathology who did not meet inclusion criteria.

Our annotated reference cohorts enrich predictive biomarker development.

Illustration of cohort indexing: showing a few patient samples in the context of disease space.

2

Consistent analysis; super-powering your pathology capabilities

Systematic, quantitative analysis of samples that accounts for molecular, demographic, and contextual data.

Enable analysis of the entire sample via our heat-mapping of the whole slide to identify areas of interest.

Interpretable and reproducible insights you can trust.

3

Immediate treatment response and disease progression insights

Our workflows enable immediate analysis and contextualisation of your patients without the need for extraneous 3rd party services that delay your pipeline and trial completion.

Enhanced monitoring of treatment-related effects permitting early detection and adaptive response from the trial team to enable safer trials.

Illustration of disease progression: showing a patient's disease features move across disease space.

Boost your histology,
start using tissue biomarkers today

We're applying tissue biomarkers to trials, research and clinical audits today. Let's talk about custom applications for your project.

Get in touch